# Interrogation of Exosome-mediated Intercellular Signaling in Patients With Pancreatic Cancer

> **NCT02393703** · — · RECRUITING · sponsor: **Memorial Sloan Kettering Cancer Center** · enrollment: 181 (estimated)

## Conditions studied

- Pancreatic Cancer
- Benign Pancreatic Disease

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT02393703
- **Lead sponsor:** Memorial Sloan Kettering Cancer Center
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2015-03
- **Primary completion:** 2027-03
- **Final completion:** 2027-03
- **Target enrollment:** 181 (ESTIMATED)
- **Last updated:** 2026-02-09

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02393703

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02393703, "Interrogation of Exosome-mediated Intercellular Signaling in Patients With Pancreatic Cancer". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT02393703. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*